Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy

Show other versions (1)

Bibliographic Details
Main Authors:	Srikant Padhi, Vinod Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Indian Journal of Ophthalmology
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=1;spage=179;epage=180;aulast=Padhi

Similar Items

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
by: Srikant Padhi, et al.
Published: (2019-01-01)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
by: Srikant Padhy, et al.
Published: (2018-01-01)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
by: Ramanuj Samanta
Published: (2019-01-01)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
by: Koushik Tripathy, et al.
Published: (2019-01-01)

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity
by: Azad Rajvardhan, et al.
Published: (2007-01-01)

Visual Outcome of Intravitreal Bevacizumab in Treatment of Diabetic Retinopathy
by: Kanwal Zareen Abbasi, et al.
Published: (2018-03-01)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
by: Shrestha R, et al.
Published: (2019-10-01)

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Osman Melih Ceylan, et al.

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Muhammet Kazim Erol, et al.
Published: (2015-12-01)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
by: Shaikh Saad
Published: (2008-01-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
by: Tsuyoshi Minami, et al.
Published: (2014-10-01)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
by: J. Fernando Arevalo, et al.
Published: (2011-01-01)

Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizuma
by: Kanwal Zareen Abbasi
Published: (2016-03-01)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment.
by: Yu-Shan Chang, et al.
Published: (2019-01-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Intravitreal bevacizumab
by: Bakulesh M Khamar
Published: (2018-01-01)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
by: Ramanuj Samanta
Published: (2019-01-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy
by: Isis A. S. Brito, et al.
Published: (2015-01-01)

Does preoperative intravitreal bevacizumab reduce complications of vitrectomy for proliferative diabetic retinopathy?
by: Daniela Véliz, et al.
Published: (2014-12-01)

Effect of intravitreal injection of Bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: Na Meng, et al.
Published: (2016-05-01)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
by: Orhan Tokgöz, et al.
Published: (2013-01-01)

Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ
by: Feng Chen, et al.
Published: (2016-07-01)

Tremendous result of bevacizumab in malignant hypertensive retinopathy
by: Ali M Al-Halafi
Published: (2015-01-01)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
by: Sidney A Schechet, et al.
Published: (2019-01-01)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
by: Caner Kara, et al.
Published: (2018-03-01)

Update - Does preoperative intravitreal bevacizumab reduce complications of vitrectomy for proliferative diabetic retinopathy?
by: Gabriel Rada
Published: (2014-12-01)

Preoperative intravitreal bevacizumab for proliferative diabetic retinopathy patients undergoing vitrectomy - First update
by: Efraín Pérez-Argandoña, et al.
Published: (2019-02-01)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
by: Fatemeh Bazvand, et al.
Published: (2021-01-01)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
by: Nasser Shoeibi, et al.
Published: (2018-03-01)

Dramatic response of iris and retinal neovascularisation following usage of intravitreal ranibizumab as pre-operative adjunct in vitrectomy for advanced proliferative diabetic retinopathy
by: Malisa A, et al.
Published: (2011)

Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity
by: Ramak Roohipoor, et al.
Published: (2019-03-01)

Effect of laser photocoagulation and bevacizumab intravitreal in proliferative diabetic retinopathy: review on biomarkers of oxidative stress
by: Andi A. Victor, et al.
Published: (2014-06-01)

Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients
by: Farhood QK, et al.
Published: (2014-03-01)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-07-01)

Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity
by: Murat Gunay, et al.
Published: (2015-10-01)

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2007-01-01)

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
by: Tomoaki Higashiyama, et al.
Published: (2017-03-01)

Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
by: Fujikawa A, et al.
Published: (2011-06-01)

Cannot write session to /tmp/vufind_sessions/sess_555a3odgtnp0a3boo8g6nb0b72